An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline<i>Versus</i>Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response

Noradrenaline may be an effective and safe alternative to terlipressin in improving renal functions. Various baseline parameters and DCD4 can be used to predict response to therapy.